ATYR
aTyr Pharma
ATYR
ATYR
36 hedge funds and large institutions have $53.1M invested in aTyr Pharma in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
49% less capital invested
Capital invested by funds: $105M → $53.1M (-$51.9M)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
85% less call options, than puts
Call options by funds: $64K | Put options by funds: $436K
Holders
36
Holding in Top 10
1
Calls
$64K
Puts
$436K
Top Buyers
| 1 | +$599K | |
| 2 | +$466K | |
| 3 | +$132K | |
| 4 |
Renaissance Technologies
New York
|
+$113K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$111K |
Top Sellers
| 1 | -$2.09M | |
| 2 | -$855K | |
| 3 | -$710K | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$197K |
| 5 |
Two Sigma Investments
New York
|
-$160K |